{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:26:01Z","timestamp":1790475961862,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL158517"],"award-info":[{"award-number":["R01 HL158517"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL160761"],"award-info":[{"award-number":["R01 HL160761"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL162830"],"award-info":[{"award-number":["R01 HL162830"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ahj.2026.107422","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:03:55Z","timestamp":1772899435000},"page":"107422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adults with repaired systemic biventricular congenital heart disease with a systemic left ventricle and heart failure with reduce ejection fraction"],"prefix":"10.1016","volume":"297","author":[{"given":"Mohamed","family":"Ellabbad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad","family":"Kholeif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser M.","family":"Ammash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Dunlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maan","family":"Jokhadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Majdalany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Egbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107422_bib0001","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107422_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2023.05.025","article-title":"Temporal changes in clinical characteristics and outcomes of adults with congenital heart disease","volume":"264","author":"Egbe","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107422_bib0003","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.ijcard.2013.03.003","article-title":"Heart failure admissions in adults with congenital heart disease; risk factors and prognosis","volume":"168","author":"Zomer","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0004","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/eurheartj\/ehq032","article-title":"Mortality in adult congenital heart disease","volume":"31","author":"Verheugt","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107422_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2016.02.133","article-title":"Cause of death in adults with congenital heart disease\u2014an analysis of the German National Register for Congenital Heart Defects","volume":"211","author":"Engelings","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009675","article-title":"Incidence and outcomes of advanced heart failure in adults with congenital heart disease","volume":"15","author":"Egbe","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2026.107422_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2022.100026","article-title":"Atherosclerotic cardiovascular disease in adults with congenital heart disease","volume":"1","author":"Egbe","year":"2022","journal-title":"JACC Adv"},{"key":"10.1016\/j.ahj.2026.107422_bib0008","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jacc.2018.08.1029","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0009","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/eurheartj\/ehaa701","article-title":"The ESC clinical practice guidelines for the management of adult congenital heart disease 2020","volume":"41","author":"Baumgartner","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107422_bib0010","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jacc.2022.01.040","article-title":"Prevalence and prognostic implications of left ventricular systolic dysfunction in adults with congenital heart disease","volume":"79","author":"Egbe","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0011","article-title":"Progressive LV dysfunction and adverse outcomes after aortic valve replacement with bioprosthetic valves in young patients","volume":"18","author":"Egbe","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2026.107422_bib0012","first-page":"183","article-title":"Prognostic value of left ventricular global longitudinal strain in patients with congenital heart disease","author":"Egbe","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2026.107422_bib0013","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2026.107422_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107422_bib0016","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107422_bib0017","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107422_bib0018","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107422_bib0019","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jchf.2020.10.002","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the heart failure collaboratory and academic research consortium","volume":"8","author":"Abraham","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107422_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchf.2020.08.016","article-title":"Putting the ``optimal'' in optimal medical therapy","volume":"9","author":"DeFilippis","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107422_bib0021","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacc.2021.11.033","article-title":"Optimal background pharmacological therapy for heart failure patients in clinical trials: JACC review topic of the week","volume":"79","author":"Fiuzat","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0022","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jacc.2024.02.017","article-title":"Effect of sodium-glucose cotransporter 2 inhibitors in adults with congenital heart disease","volume":"83","author":"Neijenhuis","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0023","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ehjcvp\/pvz014","article-title":"High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality","volume":"5","author":"Woudstra","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ahj.2026.107422_bib0024","first-page":"65","article-title":"Cardiac drugs in ACHD cardiovascular medicine","volume":"10","author":"Ladouceur","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.ahj.2026.107422_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131152","article-title":"Clinical benefits of angiotensin receptor-neprilysin inhibitor in adults with congenital heart disease","volume":"387","author":"Andi","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0026","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/heartjnl-2022-322332","article-title":"Tolerability and beneficial effects of sacubitril\/valsartan on systemic right ventricular failure","volume":"109","author":"Nederend","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2026.107422_bib0027","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2019.06.031","article-title":"Sacubitril\/valsartan for heart failure in adults with complex congenital heart disease","volume":"300","author":"Maurer","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107422_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009848","article-title":"Safety and efficacy of sacubitril\/valsartan in patients with a failing systemic right ventricle: a prospective single-center study","volume":"16","author":"Fusco","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2026.107422_bib0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.hfc.2023.12.006","article-title":"Heart failure staging and indications for advanced therapies in adults with congenital heart disease","volume":"20","author":"Egbe","year":"2024","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.ahj.2026.107422_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012595","article-title":"Clinical outcomes during admissions for heart failure among adults with congenital heart disease","volume":"8","author":"Agarwal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107422_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030649","article-title":"Mortality and morbidity of heart failure hospitalization in adult patients with congenital heart disease","volume":"12","author":"Agasthi","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107422_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009729","article-title":"A composite score summarizing use and dosing of evidence-based medical therapies in heart failure: a nationwide cohort study","volume":"16","author":"Johansen","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2026.107422_bib0033","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamacardio.2024.2969","article-title":"Hospital heart failure medical therapy score and associated clinical outcomes and costs","volume":"9","author":"Polsinelli","year":"2024","journal-title":"JAMA Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:04:41Z","timestamp":1779249881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"alternative-id":["S0002870326000840"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107422","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adults with repaired systemic biventricular congenital heart disease with a systemic left ventricle and heart failure with reduce ejection fraction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107422"}}